HK125793A - Sustained release matrix formulations - Google Patents

Sustained release matrix formulations

Info

Publication number
HK125793A
HK125793A HK1257/93A HK125793A HK125793A HK 125793 A HK125793 A HK 125793A HK 1257/93 A HK1257/93 A HK 1257/93A HK 125793 A HK125793 A HK 125793A HK 125793 A HK125793 A HK 125793A
Authority
HK
Hong Kong
Prior art keywords
sustained release
release matrix
matrix formulations
formulations
sustained
Prior art date
Application number
HK1257/93A
Other languages
English (en)
Inventor
Peter Lloyd Oren
Werner Max Karl Seidler
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of HK125793A publication Critical patent/HK125793A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
HK1257/93A 1987-02-27 1993-11-11 Sustained release matrix formulations HK125793A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1991587A 1987-02-27 1987-02-27

Publications (1)

Publication Number Publication Date
HK125793A true HK125793A (en) 1993-11-19

Family

ID=21795732

Family Applications (1)

Application Number Title Priority Date Filing Date
HK1257/93A HK125793A (en) 1987-02-27 1993-11-11 Sustained release matrix formulations

Country Status (26)

Country Link
EP (1) EP0280571B1 (lv)
JP (1) JPH082793B2 (lv)
KR (1) KR960005140B1 (lv)
CN (1) CN1023765C (lv)
AR (1) AR243376A1 (lv)
AT (1) ATE92309T1 (lv)
AU (1) AU604849B2 (lv)
CA (1) CA1316110C (lv)
CY (1) CY1741A (lv)
DE (2) DE280571T1 (lv)
DK (1) DK175620B1 (lv)
EG (1) EG18523A (lv)
ES (1) ES2044825T3 (lv)
GR (1) GR930300027T1 (lv)
HK (1) HK125793A (lv)
HU (1) HU202747B (lv)
IE (1) IE61419B1 (lv)
IL (1) IL85538A (lv)
LV (1) LV10184B (lv)
MX (1) MX10558A (lv)
NZ (1) NZ223619A (lv)
PH (1) PH24358A (lv)
PT (1) PT86831B (lv)
RU (1) RU1831337C (lv)
UA (1) UA18251A (lv)
ZA (1) ZA881301B (lv)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE527942T1 (de) * 1990-05-04 1994-03-03 Perio Prod Ltd System zur arzneistoffabgabe im colon.
IL98087A (en) * 1990-05-04 1996-11-14 Perio Prod Ltd Preparation for dispensing drugs in the colon
FR2667242B1 (fr) * 1990-09-28 1994-11-25 Rhone Poulenc Sante Nouvelles formes orales a liberation prolongee avec un temps de latence au niveau stomacal amoindri.
IT1250654B (it) * 1991-07-08 1995-04-21 Farcon Ag Metodo per la preparazione di forme farmaceutiche orali a rilascio prolungato contenenti sostanze attive a solubilita' dipendente dal valore di ph.
CA2174538A1 (en) * 1993-10-22 1995-04-27 Michio Nagasawa Base for sustained-release preparation, sustained-release preparation, and process for producing the preparation
US5695781A (en) * 1995-03-01 1997-12-09 Hallmark Pharmaceuticals, Inc. Sustained release formulation containing three different types of polymers
US5840332A (en) * 1996-01-18 1998-11-24 Perio Products Ltd. Gastrointestinal drug delivery system
DK0906089T3 (da) * 1996-05-13 2003-12-08 Novartis Consumer Health Sa Mundafgivelsessystem
CA2209868C (en) * 1997-08-15 2001-08-14 Bernard Charles Sherman Pharmaceutical compositions comprising cefuroxime axetil
JP2002505290A (ja) * 1998-03-03 2002-02-19 ダエウン ファーマシューティカル カンパニー リミテッド 水分吸収に対して安定であるセフロキシムアクセチルを含む医薬組成物
KR100296413B1 (ko) * 1998-04-01 2001-11-14 김선진 세파클러함유서방성정제
AT413647B (de) * 1998-11-26 2006-04-15 Sandoz Ag Verwendung eines copolymerisats aus 1-vinyl-2-pyrrolidon und vinylacetat zur herstellung von cefuroximaxetil-hältigen tabletten
ES2306646T3 (es) 1999-02-09 2008-11-16 Pfizer Products Inc. Composiciones de farmacos basicos con biodisponibilidad incrementada.
KR100647901B1 (ko) * 1999-07-09 2006-11-17 보령제약 주식회사 세파클러-함유 서방성 약제조성물 및 그의 제조방법
AT500063A1 (de) * 1999-11-23 2005-10-15 Sandoz Ag Beschichtete tablettenkerne
ATE396038T1 (de) 1999-12-28 2008-06-15 Kimberly Clark Co Antimikrobielles wischtuch mit kontrollierter abgabe für harte oberflächen
JP5033287B2 (ja) 1999-12-28 2012-09-26 キンバリー クラーク ワールドワイド インコーポレイテッド 吸収性物品のための使用依存型指示薬システム
US6372252B1 (en) * 2000-04-28 2002-04-16 Adams Laboratories, Inc. Guaifenesin sustained release formulation and tablets
US6419954B1 (en) * 2000-05-19 2002-07-16 Yamanouchi Pharmaceutical Co., Ltd. Tablets and methods for modified release of hydrophilic and other active agents
EP1330250B1 (en) * 2000-10-30 2004-05-12 Lupin Limited Rapidly disintegrating sustained release cefuroxime axetil composition
WO2004062577A2 (en) 2003-01-03 2004-07-29 Shire Laboratories Inc. Two or more enteric materials to regulate drug release
DE102005019458A1 (de) 2005-04-25 2006-10-26 Grünenthal GmbH Darreichungsform mit verbesserter Freisetzung von Cefuroximaxetil
EP1837020A1 (en) * 2006-03-24 2007-09-26 Bioalliance Pharma Mucosal bioadhesive slow release carrier for delivering active principles
EP2359830B1 (en) 2006-04-26 2012-09-19 Supernus Pharmaceuticals, Inc. Controlled released preparations of oxcarbazepine having sigmoidal release profile
WO2008059792A1 (fr) * 2006-11-13 2008-05-22 Kyorin Pharmaceutical Co., Ltd. Procédé de production d'un comprimé à libération prolongée
US20120029032A1 (en) 2009-03-27 2012-02-02 Kyorin Pharmaceutical Co., Ltd. Matrix-type sustained release preparation containing basic additive
US20120039999A1 (en) * 2010-08-11 2012-02-16 Ashish Chatterji Pharmaceutical compositions of metabotropic glutamate 5 receptor (mglu5) antagonists
US20120040008A1 (en) * 2010-08-11 2012-02-16 Ashish Chatterji Pharmaceutical compositions of metabotropic glutamate 5 receptor (mglu5) antagonists
CN101912373B (zh) * 2010-08-24 2012-01-04 北京京丰制药有限公司 稳定的头孢克洛分散片及其制备方法
JP6456377B2 (ja) * 2014-06-10 2019-01-23 ライオン株式会社 清酒酵母を含有する錠剤
JP7426685B2 (ja) * 2018-06-14 2024-02-02 株式会社東洋新薬 錠剤

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN151913B (lv) * 1980-01-11 1983-09-03 Boots Co Ltd
JPS6024765B2 (ja) * 1981-11-27 1985-06-14 辰巳化学株式会社 セフアレキシンの持続性製剤の製造方法
JPS601128A (ja) * 1983-06-15 1985-01-07 Shionogi & Co Ltd 作用持続型セフアクロル製剤
LU85058A1 (fr) * 1983-10-24 1985-06-19 Pharlyse Comprimes pharmaceutiques a liberation prolongee,leur preparation et leur utilisation
US4520009A (en) * 1983-11-28 1985-05-28 Verex Laboratories, Inc. Sustained released aspirin formulation
US4680323A (en) * 1983-12-01 1987-07-14 Hans Lowey Method and composition for the preparation of controlled long-acting pharmaceuticals for oral administration
JPS61286330A (ja) * 1985-06-11 1986-12-16 Teijin Ltd 経口徐放性製剤
JPS62120315A (ja) * 1985-11-20 1987-06-01 Shin Etsu Chem Co Ltd 経口投与型徐放性錠剤の製造方法

Also Published As

Publication number Publication date
CA1316110C (en) 1993-04-13
LV10184A (lv) 1994-10-20
EG18523A (en) 1993-04-30
JPS63227519A (ja) 1988-09-21
CY1741A (en) 1995-02-17
EP0280571B1 (en) 1993-08-04
ATE92309T1 (de) 1993-08-15
DE3882739T2 (de) 1994-02-17
DK98088A (da) 1988-08-28
RU1831337C (ru) 1993-07-30
AU604849B2 (en) 1991-01-03
DE280571T1 (de) 1993-08-12
ZA881301B (en) 1989-10-25
IL85538A (en) 1991-09-16
ES2044825T1 (es) 1994-01-16
CN88101062A (zh) 1988-09-07
JPH082793B2 (ja) 1996-01-17
DK98088D0 (da) 1988-02-25
KR960005140B1 (ko) 1996-04-22
EP0280571A3 (en) 1989-01-04
ES2044825T3 (es) 1994-11-16
DK175620B1 (da) 2004-12-27
PT86831B (pt) 1992-05-29
EP0280571A2 (en) 1988-08-31
HU202747B (en) 1991-04-29
IE880545L (en) 1988-08-27
HUT46531A (en) 1988-11-28
UA18251A (uk) 1997-12-25
NZ223619A (en) 1990-10-26
GR930300027T1 (lv) 1993-05-24
PH24358A (en) 1990-06-13
AR243376A1 (es) 1993-08-31
KR880009639A (ko) 1988-10-04
CN1023765C (zh) 1994-02-16
AU1219388A (en) 1988-09-01
LV10184B (en) 1995-04-20
IL85538A0 (en) 1988-08-31
IE61419B1 (en) 1994-11-02
PT86831A (pt) 1988-03-01
MX10558A (es) 1993-11-01
DE3882739D1 (de) 1993-09-16

Similar Documents

Publication Publication Date Title
AR243376A1 (es) Un procedimiento para preparar medicamentos tableteados.
NZ225101A (en) Sustained release composition
AR243378A1 (es) Procedimiento para preparar una formulacion farmaceutica de liberacion prolongada.
EP0306236A3 (en) Controlled release formulations
NZ225402A (en) Oral sustained release acetaminophen formulations
ZA878499B (en) Transdermal contraceptive formulations
PH24205A (en) Sustained release dosage forms
EP0318899A3 (en) Release agent composition
AU7942087A (en) Sustained release formulations
IL88148A0 (en) Somatotropin sustained release formulations
IE871503L (en) Sustained release formulations
SG27194G (en) Sustained release etodaloc
ZA896012B (en) Controlled release formulations
IE872675L (en) Sustained release pharmaceutical
AU663388B2 (en) Sustained release formulations
GB8922061D0 (en) Controlled release formulations
IE860577L (en) Sustained release composition
GB8705453D0 (en) Insecticidal formulations
GB8729673D0 (en) Formulations
GB8908838D0 (en) Sustained release
IE862339L (en) Disc-like sustained release formulations
IE880658L (en) Sustained release compositions
IE881744L (en) Acaricide formulations
ZA898470B (en) Sustained release preparations
GB8716488D0 (en) Release mechanism

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20080225